In glioma cells, PTPRK is involved in epidermal growth factor receptor (EGFR) and b-catenin dephosphorylation and loss of PTPRK activity results in increased EGFR and b-catenin phosphorylation [14]. Here, EGFR is linked to central nervous system cancer.